Search

Your search keyword '"Lachaier, Emma"' showing total 17 results

Search Constraints

Start Over You searched for: Author "Lachaier, Emma" Remove constraint Author: "Lachaier, Emma"
17 results on '"Lachaier, Emma"'

Search Results

1. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

2. Trastuzumab deruxtecan in previously treated HER2‐positive metastatic or unresectable breast cancer: Real‐life data from the temporary use authorization program in France

4. Abstract P4-01-20: Phase IV study evaluating talazoparib in patients with locally advanced or metastatic negative HER2 breast cancer and a somatic or germline BRCA1/2 mutation (ViTAL) – Analysis of cohort 1 according to hormonal receptor status

5. Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

6. Abstract P1-18-16: First line aromatase inhibitor (AI) + palbociclib with randomized switch to fulvestrant + palbociclib upon detection of circulating ESR1 mutation in HR+ HER2- metastatic breast cancer patients: Global safety results of PADA-1, a UCBG-GINECO phase III trial

7. Abstract GS3-05: Fulvestrant-palbociclib vs continuing aromatase inhibitor-palbociclib upon detection of circulating ESR1 mutation in HR+ HER2- metastatic breast cancer patients: Results of PADA-1, a UCBG-GINECO randomized phase 3 trial

8. Hereditary Predisposition to Acute Myeloid Leukemia in Older Adults

9. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

11. Paclitaxel-gemcitabine 3 semaines sur 4, dès la seconde ligne dans les carcinomes épidermoïdes de la tête et du cou récidivants : étude rétrospective sur 25 cas

16. Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors.

17. [Ferroptosis, a new form of cell death relevant to the medical treatment of cancer].

Catalog

Books, media, physical & digital resources